• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义肾癌细胞中臂位拷贝数变化的特征及其相关驱动因素。

Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.

机构信息

Bioinformatics Lab, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK.

Division of Cancer Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK.

出版信息

Int J Mol Sci. 2019 Nov 16;20(22):5762. doi: 10.3390/ijms20225762.

DOI:10.3390/ijms20225762
PMID:31744086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6887958/
Abstract

Using pan-cancer data from The Cancer Genome Atlas (TCGA), we investigated how patterns in copy number alterations in cancer cells vary both by tissue type and as a function of genetic alteration. We find that patterns in both chromosomal ploidy and individual arm copy number are dependent on tumour type. We highlight for example, the significant losses in chromosome arm 3p and the gain of ploidy in 5q in kidney clear cell renal cell carcinoma tissue samples. We find that specific gene mutations are associated with genome-wide copy number changes. Using signatures derived from non-negative factorisation, we also find gene mutations that are associated with particular patterns of ploidy change. Finally, utilising a set of machine learning classifiers, we successfully predicted the presence of mutated genes in a sample using arm-wise copy number patterns as features. This demonstrates that mutations in specific genes are correlated and may lead to specific patterns of ploidy loss and gain across chromosome arms. Using these same classifiers, we highlight which arms are most predictive of commonly mutated genes in kidney renal clear cell carcinoma (KIRC).

摘要

利用癌症基因组图谱 (TCGA) 的泛癌症数据,我们研究了癌细胞中拷贝数改变的模式如何既随组织类型而异,又随遗传改变的函数而变化。我们发现,染色体倍性和单个臂拷贝数的模式都依赖于肿瘤类型。例如,我们强调在肾透明细胞肾细胞癌组织样本中染色体臂 3p 的显著缺失和 5q 倍性的增加。我们发现特定的基因突变与全基因组拷贝数变化有关。使用非负因子分解得出的特征,我们还发现与特定的倍性变化模式相关的基因突变。最后,利用一组机器学习分类器,我们成功地使用臂拷贝数模式作为特征来预测样本中突变基因的存在。这表明特定基因的突变是相关的,可能导致染色体臂上特定的倍性丢失和获得模式。使用这些相同的分类器,我们强调了哪些臂最能预测肾透明细胞癌 (KIRC) 中常见的突变基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/70f234521f5c/ijms-20-05762-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/496dc5138b4a/ijms-20-05762-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/f5548a0f2b17/ijms-20-05762-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/7520f53f1ddc/ijms-20-05762-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/9f8c7bf26c63/ijms-20-05762-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/70f234521f5c/ijms-20-05762-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/496dc5138b4a/ijms-20-05762-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/f5548a0f2b17/ijms-20-05762-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/7520f53f1ddc/ijms-20-05762-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/9f8c7bf26c63/ijms-20-05762-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0990/6887958/70f234521f5c/ijms-20-05762-g005.jpg

相似文献

1
Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.定义肾癌细胞中臂位拷贝数变化的特征及其相关驱动因素。
Int J Mol Sci. 2019 Nov 16;20(22):5762. doi: 10.3390/ijms20225762.
2
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.具有透明细胞组织学和完整 VHL 及 3p 染色体的肾细胞肿瘤:癌症基因组图谱数据库中肿瘤的组织学复习。
Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.
3
Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.特定的基因组畸变可预测生存率,但在透明细胞肾细胞癌中,癌症热点区域的突变率较低。
Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):334-42. doi: 10.1097/PAI.0000000000000087.
4
Genetic and epigenetic alterations during renal carcinogenesis.肾癌发生过程中的遗传和表观遗传改变。
Int J Clin Exp Pathol. 2010 Dec 13;4(1):58-73.
5
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma.克隆结构可预测肾透明细胞癌的临床结局。
Nat Commun. 2019 Mar 18;10(1):1245. doi: 10.1038/s41467-019-09241-7.
6
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.冯·希佩尔-林道病相关及散发性肾透明细胞癌中的基因表达模式和拷贝数改变
Cancer Res. 2009 Jun 1;69(11):4674-81. doi: 10.1158/0008-5472.CAN-09-0146.
7
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.原发性肾细胞癌中冯·希佩尔-林道(VHL)肿瘤抑制基因的失活及3号染色体短臂的等位基因缺失:透明细胞肾肿瘤发生中存在不依赖VHL途径的证据
Genes Chromosomes Cancer. 1998 Jul;22(3):200-9. doi: 10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-#.
8
Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.透明细胞乳头状肾细胞癌:分子和免疫组织化学分析,重点关注 von Hippel-Lindau 基因和缺氧诱导因子通路相关蛋白。
Mod Pathol. 2011 Sep;24(9):1207-20. doi: 10.1038/modpathol.2011.80. Epub 2011 May 20.
9
Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.巴西患者肾透明细胞癌中的体细胞拷贝数改变及相关基因
Int J Mol Sci. 2021 Feb 25;22(5):2265. doi: 10.3390/ijms22052265.
10
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.追踪肾脏研究:明确肾细胞癌演进过程中的里程碑事件。
Cell. 2018 Apr 19;173(3):611-623.e17. doi: 10.1016/j.cell.2018.02.020. Epub 2018 Apr 12.

引用本文的文献

1
ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway.锌指蛋白692通过靶向代谢途径促进透明细胞肾癌细胞的迁移及对免疫疗法的反应。
Discov Oncol. 2024 May 12;15(1):158. doi: 10.1007/s12672-024-01005-0.
2
PTK6: An emerging biomarker for prognosis and immunotherapeutic response in clear cell renal carcinoma (KIRC).PTK6:肾透明细胞癌(KIRC)预后及免疫治疗反应的新兴生物标志物。
Heliyon. 2024 Mar 29;10(7):e29001. doi: 10.1016/j.heliyon.2024.e29001. eCollection 2024 Apr 15.
3
Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis.

本文引用的文献

1
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.癌症基因组图谱中TP53基因与通路改变的综合分析
Cell Rep. 2019 Sep 10;28(11):3010. doi: 10.1016/j.celrep.2019.08.061.
2
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.基于多组学的肾细胞癌分类法
Cell Rep. 2016 Mar 15;14(10):2476-89. doi: 10.1016/j.celrep.2016.02.024. Epub 2016 Mar 3.
3
Aneuploidy as a mechanism of adaptation to telomerase insufficiency.非整倍体作为一种适应端粒酶不足的机制。
通过单细胞转录组分析绘制透明细胞肾细胞癌的肿瘤微环境
Front Genet. 2023 Jul 18;14:1207233. doi: 10.3389/fgene.2023.1207233. eCollection 2023.
4
The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer.凋亡基因和蛋白质-蛋白质相互作用在三阴性乳腺癌中的作用。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):247-272. doi: 10.21873/cgp.20379.
5
The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer.化疗耐药基因BIRC5在三阴性乳腺癌中的预后及治疗意义
Cancers (Basel). 2022 Oct 22;14(21):5180. doi: 10.3390/cancers14215180.
6
The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.锌指蛋白 433 被鉴定为透明细胞肾细胞癌的一种潜在预后生物标志物。
Biomolecules. 2021 Aug 12;11(8):1193. doi: 10.3390/biom11081193.
7
Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden.具有超高肿瘤突变负荷的泛癌患者的特征
Front Oncol. 2021 Apr 22;11:682017. doi: 10.3389/fonc.2021.682017. eCollection 2021.
Curr Genet. 2016 Aug;62(3):557-64. doi: 10.1007/s00294-015-0559-x. Epub 2016 Jan 12.
4
SnapShot: Renal Cell Carcinoma.快照:肾细胞癌。
Cell. 2015 Dec 3;163(6):1556-1556.e1. doi: 10.1016/j.cell.2015.11.026.
5
Amplification of Cellular Oncogenes in Solid Tumors.实体瘤中细胞癌基因的扩增
N Am J Med Sci. 2015 Aug;7(8):341-6. doi: 10.4103/1947-2714.163641.
6
Aneuploidy.非整倍性
Curr Biol. 2015 Jun 29;25(13):R538-42. doi: 10.1016/j.cub.2015.05.010.
7
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.癌症基因组图谱(TCGA):一个不可估量的知识来源。
Contemp Oncol (Pozn). 2015;19(1A):A68-77. doi: 10.5114/wo.2014.47136.
8
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.将基因突变与基因表达数据相结合可改善骨髓增生异常综合征的预后预测。
Nat Commun. 2015 Jan 9;6:5901. doi: 10.1038/ncomms6901.
9
DNA double-strand break repair pathway choice and cancer.DNA双链断裂修复途径的选择与癌症
DNA Repair (Amst). 2014 Jul;19:169-75. doi: 10.1016/j.dnarep.2014.03.014. Epub 2014 Apr 18.
10
BAF180 promotes cohesion and prevents genome instability and aneuploidy.BAF180促进黏连并防止基因组不稳定和非整倍体形成。
Cell Rep. 2014 Mar 27;6(6):973-981. doi: 10.1016/j.celrep.2014.02.012. Epub 2014 Mar 6.